Impact of Cross-training on Induction Treatment Response in Acute Lymphoblastic Leukemia Adults
NCT05059847 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114
Last updated 2021-09-28
Summary
Despite advances in the treatment of acute lymphoblastic leukemia, the prognosis in adults is still poor, largely due to the resistance of treatment at diagnosis or early relapse. Among the strategies associated with the treatment of Acute Lymphoblastic Leukemia is rehabilitation and physical medicine in order to improve the quality of life, body composition, fitness, strength and improve the attachment and acceptance of their treatment
Conditions
- Acute Lymphoblastic Leukemia, Adult B-Cell
Interventions
- OTHER
-
Training
Training routine assigned by randomized chart
Sponsors & Collaborators
-
Hospital General de Mexico
lead OTHER_GOV
Principal Investigators
-
Adolfo Martinez Tovar, PhD · Hospital General de Mexico
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 39 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-09-06
- Primary Completion
- 2023-01-13
- Completion
- 2023-05-19
Countries
- Mexico
Study Locations
More Related Trials
-
COaching and Prehabilitation: Faisability Study in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
NCT03595787 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
the Efficacy and Safety of Total Myeloid Irradiation (TMI) in the Treatment of Adult Acute Lymphoblastic Leukemia
NCT06461091 ·Status: NOT_YET_RECRUITING
-
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
NCT03204916 ·Status: COMPLETED
-
ALL-Active: A Family-Based Lifestyle Program for Pediatric Acute Leukemia Patients
NCT01901367 ·Status: COMPLETED ·Phase: NA
-
Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
NCT00061945 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AML
NCT02094794 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Effect of Digital Health Coaching Program on Self-efficacy and Patient Reported Outcomes of Patients With Newly Diagnosed Acute Myeloid Leukemia or Chronic Lymphocytic Leukemia
NCT04774744 ·Status: COMPLETED ·Phase: NA
-
Acute Lymphoblastic Leukemia Relapse in Sweden 2003-2007
NCT01470924 ·Status: COMPLETED
-
Total Body Irradiation and Cladribine Before Allogeneic Hematopoietic Cell Transplantation in Patients With AML (Acute Myeloid Leukemia) and Myelodysplastic Syndromes
NCT04861207 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Multicenter Study of Combined Chemotherapy and Transplantation for Adult ALL
NCT07059156 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Impact of a Pharmaceutical Care Model in the Management of Chronic Myeloid Leukemia Patients
NCT03090477 ·Status: COMPLETED ·Phase: NA
-
Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases
NCT05800210 ·Status: RECRUITING ·Phase: PHASE2
-
Fludarabine / Total Body Irradiation Regimen for ALLO HCT in Acute Lymphoblastic Leukemia
NCT01991457 ·Status: COMPLETED ·Phase: PHASE2
-
Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia
NCT00005801 ·Status: COMPLETED ·Phase: PHASE2
-
Ph 1 Study of ADI-PEG 20 Plus Low Dose Cytarabine in Older Patients With AML
NCT02875093 ·Status: TERMINATED ·Phase: PHASE1
-
Treatment of Adult ALL With an MRD-directed Programme.
NCT00358072 ·Status: COMPLETED ·Phase: PHASE2
-
Addition of Gemcitabine to Pre Allo-HSCT Conditioning for Acute Lymphoblastic Leukemia
NCT03339700 ·Status: UNKNOWN ·Phase: PHASE2
-
S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML
NCT00085709 ·Status: COMPLETED ·Phase: PHASE3
-
Anti-Leukemia Immune Responses After Irradiation of Extramedullary Tumors
NCT05035706 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00558519 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Management and Prognosis of Patients With Acute Myeloblastic Leukemia in Saint-Antoine Hospital
NCT05558943 ·Status: NOT_YET_RECRUITING
-
Endothelial Function, Arterial Stiffness and Components
NCT01439217 ·Status: COMPLETED
-
Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
NCT04530565 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Refining the Role of Mid-induction Bone Marrow Biopsy in Acute Myeloid Leukemia: A Pilot Study
NCT06323590 ·Status: ACTIVE_NOT_RECRUITING
-
Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma
NCT00195871 ·Status: UNKNOWN ·Phase: PHASE2